The univariate results showed that tumor grade, surgical resection range, preoperative KPS score, postoperative radiotherapy and chemotherapy, IDH1/2 gene and TERT promoter mutation were the influencing factors of postoperative survival of patients with glioma. This evidence concerns the gene TERT and central nervous system cancer.